A Houston physician has sued the federal government to cut benefits through the Affordable Care Act that requires access to ...

As politicians, activists and researchers duke it out from labs and clinics and press conferences, those who have the most to ...

Later this month, the Food and Drug Administration is widely expected to approve a groundbreaking twice-yearly injection to ...

Of 49 countries surveyed in a recent analysis, 15 have historically relied on the the U.S. for most of the funding for their ...

Gilead's HIV drug lenacapavir earns FDA priority review after strong trial results, with the company planning to double U.S.

The current administration has pulled millions in HIV-related grants and cut staffing positions essential to research and ...

Eight times more young Americans are taking antiretroviral meds to protect them from HIV infection than a decade ago, a new ...

Nina E. Hill, MD, from the University of Michigan in Ann Arbor, and colleagues examined recent trends in HIV PrEP among young adults (aged 18 to 25 years). The analysis included data from the IQVIA ...

A population-based study finds that nearly 15% of individuals using HIV preexposure prophylaxis are diagnosed with alcohol ...

In Philippi village in the Western Cape of South Africa, 24-year-old Simamkele Matinise works at an HIV-prevention mobile ...

HIV prevention used to be wrapped in red tape, judgment, and long doctor visits. But Mistr is flipping the whole system on ...

Lenacapavir works to both treat and prevent HIV, making it a promising drug should it be approved by the FDA later this month.